Effects of CYP2C19*17 Genetic Polymorphisms on the Steady-State Concentration of Diazepam in Patients With Alcohol Withdrawal Syndrome:

Valentin Yurievich Skryabin,Mikhail S. Zastrozhin,Marco Torrado,Elena A. Grishina,Kristina A. Ryzhikova,Valery V. Shipitsyn,Tatiana E. Galaktionova,Alexander S. Sorokin,Evgeny A. Bryun,Dmitry A. Sychev

Effects of CYP2C19*17 Genetic Polymorphisms on the Steady-State Concentration of Diazepam in Patients With Alcohol Withdrawal Syndrome:

2020

Valentin Yurievich Skryabin
Mikhail S. Zastrozhin
Marco Torrado
Elena A. Grishina
Kristina A. Ryzhikova
Valery V. Shipitsyn
Tatiana E. Galaktionova
Alexander S. Sorokin
Evgeny A. Bryun
Dmitry A. Sychev

Background: Diazepam is one of the most widely prescribed tranquilizers for the therapy of alcohol withdrawal syndrome (AWS), which includes the symptoms of anxiety, fear, and emotional tension. Ho...

Keywords:

Alcohol withdrawal syndrome
Anesthesia
CYP2C19
Pharmacogenetics
Emergency medicine
Diazepam
emotional tension
in patient
Personalized medicine
Anxiety
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations